Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Acute kidney injury (AKI) has been identified as an independent risk factor for in-hospital mortality. The present study aims to investigate the incidence of AKI and renal recovery of inpatients diagnosed with COVID-19.
Beginning in December 2019, a novel coronavirus, designated as severe acute respiratory distress coronavirus 2 (SARS-CoV-2), has caused an international outbreak of respiratory illness termed coronavirus disease 2019 (COVID-19). Although the clinical manifestations of COVID-19 are dominated by respiratory symptoms, some patients show severe kidney abnormalities. Acute kidney injury (AKI) has been identified as an independent risk factor for in-hospital mortality. The present study aims to investigate the incidence of AKI and renal recovery of inpatients diagnosed with COVID-19.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| ICU patients | Inpatients with COVID-19 requiring ICU care | ||
| Non-ICU patients | Inpatients with COVID-19 not requiring ICU care |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of AKI | Serial assessment of serum creatinine and urine output | 30 days post-hospital admission |
| Cystatin C as indicator of mortality | All-cause mortality | 30 days post-hospital admission |
| Cystatin C as indicator of renal disease | AKI and acute kidney disease (AKD) | 30 days post-hospital admission |
| Cystatin C as indicator of respiratory illness | Ventilator-free days | 30 days post-hospital admission |
| Cystatin C as indicator of disease severity | Rate of intensive care unit admission | 30 days post-hospital admission |
Not provided
Not provided
Inclusion Criteria:
1) Patients with COVID-19 diagnosed by World Health Organisation (WHO) criteria
Exclusion Criteria:
Not provided
Not provided
Not provided
Hospitalized patients with diagnosed COVID-19
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Werner Seeger, MD | University Hospital Giessen and Marburg, Giessen | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospital Giessen and Marburg, Giessen | Giessen | Hesse | 35382 | Germany |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 32204907 | Result | Naicker S, Yang CW, Hwang SJ, Liu BC, Chen JH, Jha V. The Novel Coronavirus 2019 epidemic and kidneys. Kidney Int. 2020 May;97(5):824-828. doi: 10.1016/j.kint.2020.03.001. Epub 2020 Mar 7. No abstract available. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D058186 | Acute Kidney Injury |
| D018352 | Coronavirus Infections |
| ID | Term |
|---|---|
| D051437 | Renal Insufficiency |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| D005261 |
| Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D014777 | Virus Diseases |
| D007239 | Infections |